Encrypted | Login

2019 AAPM Annual Meeting - Session: Rationale and Evidence for SBRT Q & A


This video is currently visible only to AAPM Members, Affiliates and Developing Country Educational Associates. Embargo periods are typically one year from the date the presentation was first published.


Q & A




When you have finished the video, you may watch again, browse/search all videos, go back to the previous page, or watch another video in this session (see below).



All videos in this session:
Introduction - Jimm Grimm, PhD Johns Hopkins University
Radiation Therapy Dose Response Modeling and Optimization of Fractionation Schedules with Cancer Stem Cells - Victoria Yu, MS UCLA School of Medicine
Role of Vascular Damage and Tumor Microenvironment in the Response of Tumors to SBRT and SRS - Chang Song, University of Minnesota Medical School
Biological Dose Escalation and Outcomes Modeling in the Era of Stereotactic Radiotherapy - David Carlson, PhD University of Pennsylvania
Immunomodulatory Effects of Stereotactic Body Radiation Therapy (SBRT): Preclinical Insights and Clinical Opportunities - Ariel Marciscano, Memorial Sloan Kettering Cancer Center
Graph includes 43 member loads and 150 non-member loads (193 total loads). Exclude non-member? A load is defined as someone coming to this page, not necesarily that they pressed play, or watched the entire presentation.